Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,808Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8AZURITY

02 10MEDEXUS

03 112OTTER PHARMS

04 6SHORLA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHOTREXATE SODIUM

US Patent Number : 10231927

Drug Substance Claim :

Drug Product Claim :

Application Number : 208400

Patent Use Code : U-1699

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2033-01-02

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHOTREXATE SODIUM

US Patent Number : 10231927

Drug Substance Claim :

Drug Product Claim :

Application Number : 208400

Patent Use Code : U-1349

Delist Requested :

Patent Use Description : TREATMENT OF JUVENILE ...

Patent Expiration Date : 2033-01-02

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHOTREXATE SODIUM

US Patent Number : 11116724

Drug Substance Claim :

Drug Product Claim :

Application Number : 208400

Patent Use Code : U-1349

Delist Requested :

Patent Use Description : TREATMENT OF JUVENILE ...

Patent Expiration Date : 2033-01-02

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHOTREXATE SODIUM

US Patent Number : 11116724

Drug Substance Claim :

Drug Product Claim :

Application Number : 208400

Patent Use Code : U-1699

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2033-01-02

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHOTREXATE SODIUM

US Patent Number : 11969503

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208400

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-01-02

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHOTREXATE SODIUM

US Patent Number : 10610485

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208400

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-01-02

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHOTREXATE SODIUM

US Patent Number : 9855215

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208400

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-01-02

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHOTREXATE SODIUM

US Patent Number : 9259427

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208400

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-01-02

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHOTREXATE

US Patent Number : 8664231

Drug Substance Claim :

Drug Product Claim :

Application Number : 205776

Patent Use Code : U-1442

Delist Requested :

Patent Use Description : SUBCUTANEOUS INJECTION...

Patent Expiration Date : 2029-06-01

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHOTREXATE

US Patent Number : 8664231

Drug Substance Claim :

Drug Product Claim :

Application Number : 205776

Patent Use Code : U-1442

Delist Requested :

Patent Use Description : SUBCUTANEOUS INJECTION...

Patent Expiration Date : 2029-06-01

blank